Kimia Farma (Indonesia) Management Evaluation
| KAEF Stock | IDR 386.00 36.00 8.53% |
Kimia Farma employs about 11.5 K people. The company is managed by 19 executives with a total tenure of roughly 87 years, averaging almost 4.0 years of service per executive, having 605.84 employees per reported executive. Inspection of Kimia Farma's management performance can provide insight into the company performance.
| Honesti Basyir President President Director |
| Untung Sutarjo President President Commissioner |
Kimia |
Kimia Farma Management Team Effectiveness
Kimia Farma's management efficiency ratios could be used to measure how well Kimia Farma manages its routine affairs as well as how well it operates its assets and liabilities.Kimia Farma Workforce Comparison
Kimia Farma Persero is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 40,169. Kimia Farma totals roughly 11,511 in number of employees claiming about 29% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03. Kimia Farma Persero Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Kimia Farma Persero Price Series Summation is a cross summation of Kimia Farma price series and its benchmark/peer.
Kimia Farma Notable Stakeholders
A Kimia Farma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kimia Farma often face trade-offs trying to please all of them. Kimia Farma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kimia Farma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Honesti Basyir | President Director | Profile | |
| Untung Sutarjo | President Commissioner | Profile | |
| Pujianto | Business Development Director | Profile | |
| Arief Pramuhanto | Human Capital and General Affairs Director | Profile | |
| Verdi Budidarmo | Production and Supply Chain Director | Profile | |
| David Utama | Pres Director | Profile | |
| I Wijaya | Finance Director | Profile | |
| Jasmine Karsono | RD Marketing | Profile | |
| Nurrachman | Independent Commissioner | Profile | |
| CIA CPIA | Head Audit | Profile | |
| Ganti Putro | Corporate Secretary | Profile | |
| Dharma MM | HR Director | Profile | |
| Lina MM | F Director | Profile | |
| MM Apt | Director Director | Profile | |
| Wahono Sumaryono | Independent Commissioner | Profile | |
| Chrisma Albandjar | Commissioner | Profile | |
| Eva Fairus | Gen Sales | Profile | |
| Muhammad Fauzi | Commissioner | Profile | |
| Rosrini | Compliance Mang | Profile |
About Kimia Farma Management Performance
The success or failure of an entity such as Kimia Farma Persero often depends on how effective the management is. Kimia Farma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kimia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kimia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PT Kimia Farma Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company was founded in 1817 and is headquartered in Jakarta, Indonesia. Kimia Farma operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 11772 people.
Kimia Farma Workforce Analysis
Traditionally, organizations such as Kimia Farma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kimia Farma within its industry.Kimia Farma Manpower Efficiency
Return on Kimia Farma Manpower
| Revenue Per Employee | 1.1B | |
| Revenue Per Executive | 676.7B | |
| Net Income Per Employee | 26.3M | |
| Net Income Per Executive | 15.9B |
Other Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.